JOURNAVX®: Opioid-Free Recovery Post-Surgery Data Revealed
New Phase 4 data shows Vertex’s JOURNAVX® (suzetrigine) enables 76% opioid-free recovery after laparoscopic & arthroscopic surgeries in multimodal therapy. Reduces opioid use.
New Phase 4 data shows Vertex’s JOURNAVX® (suzetrigine) enables 76% opioid-free recovery after laparoscopic & arthroscopic surgeries in multimodal therapy. Reduces opioid use.